JP2023179436A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023179436A5 JP2023179436A5 JP2023138247A JP2023138247A JP2023179436A5 JP 2023179436 A5 JP2023179436 A5 JP 2023179436A5 JP 2023138247 A JP2023138247 A JP 2023138247A JP 2023138247 A JP2023138247 A JP 2023138247A JP 2023179436 A5 JP2023179436 A5 JP 2023179436A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated protein
- seq
- amino acid
- protein
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000018102 proteins Nutrition 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 26
- 102000004169 proteins and genes Human genes 0.000 claims 26
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 4
- 150000002632 lipids Chemical class 0.000 claims 4
- 239000012528 membrane Substances 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 235000004279 alanine Nutrition 0.000 claims 3
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17306255.5 | 2017-09-22 | ||
| EP17306255 | 2017-09-22 | ||
| PCT/EP2018/075824 WO2019057974A1 (en) | 2017-09-22 | 2018-09-24 | GLYCOPROTEIN MUTATED FROM VESICULAR STOMATITIS VIRUS |
| JP2020516534A JP2020534007A (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516534A Division JP2020534007A (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023179436A JP2023179436A (ja) | 2023-12-19 |
| JP2023179436A5 true JP2023179436A5 (es) | 2024-07-05 |
Family
ID=60153233
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516534A Pending JP2020534007A (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
| JP2023138247A Pending JP2023179436A (ja) | 2017-09-22 | 2023-08-28 | 変異型ウイルスタンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516534A Pending JP2020534007A (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20200216502A1 (es) |
| EP (1) | EP3684786A1 (es) |
| JP (2) | JP2020534007A (es) |
| CA (1) | CA3076094A1 (es) |
| WO (1) | WO2019057974A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3708176A1 (en) * | 2019-03-15 | 2020-09-16 | Centre National De La Recherche Scientifique -Cnrs- | Mutant vsv ectodomain polypeptide and uses thereof |
| AU2020278470A1 (en) * | 2019-05-23 | 2021-12-02 | Massachusetts Institute Of Technology | Ligand discovery and gene delivery via retroviral surface display |
| EP4013459A4 (en) * | 2019-08-16 | 2023-09-06 | Mayo Foundation for Medical Education and Research | CHIMERIC VESICULOVIRUSES AND THEIR METHODS OF USE |
| EP4087858A1 (en) * | 2020-01-10 | 2022-11-16 | Carogen Corporation | Compositions and methods of use of oncolytic virus like vesicles |
| WO2021158878A1 (en) * | 2020-02-06 | 2021-08-12 | Boehringer Ingelheim Animal Health USA Inc. | Polypeptides useful for detecting anti-rhabdovirus antibodies |
| AU2022212952A1 (en) | 2021-01-27 | 2023-08-10 | Umoja Biopharma, Inc. | Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor |
| CN112852757A (zh) * | 2021-02-01 | 2021-05-28 | 南京大学 | 一种制备新型溶瘤病毒EM/VSV-G Ad5sPVRCD137L的方法 |
| IL312832A (en) * | 2021-12-06 | 2024-07-01 | Univ Leland Stanford Junior | Methods and compositions for detecting receptor-ligand specificity by feeding transgenic cells |
| CA3239267A1 (en) | 2021-12-15 | 2023-06-22 | Ronnie M. RUSSELL | Pseudotyped viral particles, compositions comprising the same, and uses thereof |
| IL291148A (en) * | 2022-03-06 | 2023-10-01 | Noga Therapeutics Ltd | Lentiviral vectors that bind to hematopoietic cells |
| WO2023225569A1 (en) | 2022-05-17 | 2023-11-23 | Umoja Biopharma, Inc. | Manufacturing viral particles |
| WO2024050450A1 (en) | 2022-08-31 | 2024-03-07 | Gigamune, Inc. | Engineered enveloped vectors and methods of use thereof |
| WO2024097992A2 (en) | 2022-11-04 | 2024-05-10 | Umoja Biopharma, Inc. | Particles displaying adhesion-molecule fusions |
| WO2024098028A2 (en) | 2022-11-04 | 2024-05-10 | Umoja Biopharma, Inc. | Lentiviral particles displaying fusion molecules and uses thereof |
| WO2024098038A2 (en) | 2022-11-04 | 2024-05-10 | Umoja Biopharma, Inc. | Polynucleotide construct and related viral vectors and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL148621A0 (en) * | 1999-09-17 | 2002-09-12 | Pro Virus Inc | Oncolytic virus |
| KR20040095217A (ko) * | 2002-02-07 | 2004-11-12 | 델타 바이오테크놀로지 리미티드 | 알부민-융합 항-혈관신생 펩타이드 |
| JP4411523B2 (ja) * | 2004-03-04 | 2010-02-10 | 株式会社日健総本社 | 抗ウイルス剤 |
| US8008268B2 (en) * | 2006-07-25 | 2011-08-30 | Merial Limited | Vaccines against vesicular stomatitis |
| HUE033517T2 (en) * | 2007-08-03 | 2017-12-28 | Pasteur Institut | Defective non-integrating lentivirus transfer vectors for vaccines |
| WO2009019612A2 (en) * | 2007-08-03 | 2009-02-12 | Institut Pasteur | Lentiviral gene transfer vectors and their medicinal applications |
| AU2012396787B9 (en) * | 2012-12-12 | 2019-10-03 | Turnstone Limited Partnership | Compositions and methods for the treatment of brain cancers |
-
2018
- 2018-09-24 US US16/649,271 patent/US20200216502A1/en active Pending
- 2018-09-24 CA CA3076094A patent/CA3076094A1/en active Pending
- 2018-09-24 EP EP18773448.8A patent/EP3684786A1/en active Pending
- 2018-09-24 JP JP2020516534A patent/JP2020534007A/ja active Pending
- 2018-09-24 WO PCT/EP2018/075824 patent/WO2019057974A1/en unknown
-
2023
- 2023-08-28 JP JP2023138247A patent/JP2023179436A/ja active Pending
- 2023-09-25 US US18/473,720 patent/US12030915B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023179436A5 (es) | ||
| ES2839880T3 (es) | Vacuna contra el VRS | |
| WO2022206222A1 (zh) | 一种新型冠状病毒s-rbd三聚体蛋白疫苗、其制备方法和应用 | |
| WO2012172277A4 (en) | Simian adenovirus and hybrid adenoviral vectors | |
| JP2013520426A5 (es) | ||
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| CN115297892A (zh) | 抗新型冠状病毒感染的mRNA疫苗的组合物和方法 | |
| JPWO2019193119A5 (es) | ||
| JP2015509707A5 (es) | ||
| WO2021198706A3 (en) | Coronavirus vaccines | |
| JP2014527072A5 (es) | ||
| JP2020517260A5 (es) | ||
| CA2692358A1 (en) | Recombinant human interferon-like proteins | |
| AR125406A1 (es) | Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen | |
| JP2002539781A5 (es) | ||
| MX2023008825A (es) | Efecto sinergico de smn1 y mir-23a en el tratamiento de la atrofia muscular espinal. | |
| Wang et al. | Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins | |
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| JP2011521648A5 (es) | ||
| JPWO2021116462A5 (es) | ||
| JPWO2021007529A5 (es) | ||
| JPWO2019197567A5 (es) | ||
| JPWO2022158453A5 (es) | ||
| JP2023509666A (ja) | 分子の細胞内送達用の多量体化送達システム | |
| JP2009506025A (ja) | 抗ウイルス剤及びウイルス複製阻害剤 |